GO Term | Evidence Code | PMID |
---|---|---|
defense response to virus | ||
regulation of response to type II interferon | ||
positive regulation of transcription, DNA-templated | ||
positive regulation of tyrosine phosphorylation of STAT protein | ||
DNA damage checkpoint signaling |
GO Term | Evidence Code | PMID |
---|---|---|
NAD+ ADP-ribosyltransferase activity | ||
ADP-D-ribose binding | ||
histone binding | ||
NAD+-protein ADP-ribosyltransferase activity | ||
enzyme binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:5823 | childhood lymphoma | |
DOID:5825 | adult lymphoma | |
DOID:5870 | eosinophilic pneumonia | |
DOID:615 | leukopenia | |
DOID:6193 | epithelioid sarcoma | |
DOID:626 | complement deficiency | |
DOID:6688 | autoimmune lymphoproliferative syndrome | |
DOID:684 | hepatocellular carcinoma | |
DOID:707 | B-cell lymphoma | |
DOID:7148 | rheumatoid arthritis |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115608852 | STRHB04086 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024